- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05022953
The Effect of Digital Storytelling on Nursing Students' Compliance
The Effect of Digital Storytelling on Nursing Students' Compliance With Isolation Precautions and Their Knowledge Levels: A Randomized Controlled Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Trabzon, Turquie
- Şule BIYIK BAYRAM
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Being voluntary
- Having access to the Internet
Exclusion Criteria:
- Not attending the digital storytelling activity (intervention)
- Not taking the posttest
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Digital Story Group
Digital Story Group: One of the researchers gave the experimental group participants a 15-minute briefing on how to perform digital storytelling.
She also told them not to talk to the control group participants about the content of the briefing.
She created a Pixton account (https://edu.pixton.com/educators/)
and a class named "Isolation."
She sent the link (https://join.pixton.com/x5xb6) to the experimental group participants.
She asked them to click on the link and make stories out of their knowledge of isolation in four weeks.
|
Digital story
|
|
Aucune intervention: Control Group
Control group participants did not go through any training in isolation.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Distribution of students according to descriptive characteristics.
Délai: 1 month
|
The 11-item demographic characteristics questionnaire was based on a literature review conducted by the researchers (Özden and Özveren, 2016; Orabi, 2017; Sarier and Kurşun, 2020). The experimental and control group participants had a mean age of 22.57±2.28 and 21.79±0.80, respectively. The experimental group consisted of 56 women and ten men. The control group consisted of 38 women and six men |
1 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The difference between the pre, post and follow-up knowledge scores of the control and experimental group students
Délai: 1 month
|
The Isolation Knowledge Test (IKT) was based on a literature review conducted by the researchers (Erden et al., 2015, Doğanay et al., 2013, Karabay et al., 2018). Three experts in nursing fundamentals were consulted to develop the test. The draft test consisted of 40 statements. A pilot study was conducted to check for the intelligibility and relevance of the statements and to calculate item difficulty and item discrimination indices. was a significant difference between pretest and posttest IKT scores in the experimental group (p=0.01). There was also a significant difference between posttest and follow-up IKT scores in the experimental group (p=0.01). The experimental group had significantly higher follow-up IKT scores than pretest scores. |
1 month
|
|
The difference between the control and experimental group scores according to the total and sub-dimensions of the scale
Délai: 2 months
|
The Scale of Compliance with Isolation Precautions (SCIP) was developed by Tayran and Ulupınar (2011). The scale consists of 18 items scored on a five-point Likert-type scale ("1 = Strongly disagree," "2 = Disagree," "3 = Neither agree nor disagree," "4 = Agree," "5 = Strongly agree"). The scale has a Cronbach's Alpha of 0.85 (Tayran & Ulupınar, 2011), which was 0.86 (pretest) and 0.78 (posttest) in the present study. There was no significant difference in pretest SCIP scores between the experimental and control groups. However, there was a significant difference in posttest SCIP scores between them. The experimental group had significantly higher posttest SCIP scores than pretest scores (p=0.00). It had significantly higher follow-up SCIP scores than posttest and pretest scores. There was no significant difference between the control group's pretest, posttest, and follow-up SCIP scores |
2 months
|
|
The following are quotations from the experimental group participants about digital storytelling.
Délai: 2 months
|
The Questionnaire of Students' Opinions on Digital Storytelling (QSODS) consisted of three open-ended questions on (1) the contribution of digital storytelling to learning, (2) the effect of digital storytelling on students' compliance with isolation precautions and knowledge levels, and (3) students' opinions about digital storytelling. The following are quotations from the experimental group participants about digital storytelling. "I realized that I had some gaps in my knowledge of isolation methods and protective measures. It [digital storytelling] helped me fill those gaps." [Student (S). 10]. I think that it's [digital storytelling] fun and instructive. I helped me go over what I already knew and learn new stuff (S.12). We've had distance learning for a long time, so this storytelling thing helped me feel like I was in it" (S. 54). |
2 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Emel Gulnar, PhD, Kırıkkale University
- Chaise d'étude: Nurcan Caliskan, PhD, Gazi University
- Chaise d'étude: Cigdem Torun Kılıc, Msc, Karadeniz Teknik University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- KaradenizTU-1
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .